Monday, December 5, 2016

9:00 a.m. – 12:00 p.m. (Registration and Continental Breakfast at 8:30 a.m.)

Preparing the Rising Stars of the Products Liability Defense Bar: Meeting In-House Counsel’s Expectations for Deposition Strategy, Prep, and Execution
Patricia A. Barbieri
Deputy General Counsel, Legal Affairs
Daiichi Sankyo, Inc. (Parsippany, NJ)
Michael P. Panagrossi
Associate General Counsel
Purdue Pharma L.P. (Stamford, CT)
Jobina Jones McDonnell
Litigation Counsel
Endo Pharmaceuticals (Malvern, PA)
Andrew K. Solow
Kaye Scholer LLP (New York, NY)
In this session, leading members of the drug and med bar will share the insights that they have gained in the trenches of litigation and will
give attendees the nuanced information they need to stand out in this competitive field. More than just a primer on defending mass torts,
this session will increase the value of the next generation of the defense bar to their pharmaceutical and medical device clients by honing in
on one key area where cases are made or broken: taking depositions for plaintiffs, treating physicians, prescribing physicians, and experts.

12:30 In-House Think Tank Lunch (by Invite Only)

Only for in-house counsel, this working lunch will provide a forum to discuss the state of the industry candidly with your peers
on how members of the defense bar can coordinate their advocacy efforts for 2017 to match those of a highly organized and well-funded
plaintiffs’ bar.

Monday, December 5, 2016
2:30 p.m. – 5:00 p.m. (Registration begins at 1:30 p.m.)
Lessons Learned From 2016’s Biggest Defense Victories and Most Challenging Rulings

Moderated by:

James M. Holston
Managing Counsel, Office of General Counsel
Merck & Co., Inc. (North Wales, PA)

Steve Phillips
Special Counsel
Medtronic, Inc.
Connie Matteo
Assistant General Counsel
Pfizer Inc. (New York, NY)
Open to defense counsel only, join your peers for a state-of-the-industry analysis and candid discussion about the latest and greatest in plaintiffs’ tactics. In-house and law firm defense counsel are encouraged to participate in this unique, interactive networking session that will set the stage for the topics discussed in-depth throughout the event and provide you with valuable takeaways about what your peers from around the country are seeing from the plaintiffs’ bar.

Please come prepared to discuss the following:

  • Updates on select mass torts, ellwether trials, and key
    state court proceedings from around the country: what
    tactics and themes are plaintiffs’ attorneys using?
  • Proactively identifying drugs or devices which may be ripe
    for litigation in 2017 and beyond in light of adverse event
    reports, social media postings, and attorney advertising
  • Overview of key plaintiffs’ firms and third party players: who
    is driving the litigation?
  • Motions to dismiss: on what grounds have you seen success?
  • Good science and bad science: sharing literature that is relevant to the defense perspective regarding causation
  • Expert witnesses: who are the frequent testifiers?
  • Deconstructing recent noteworthy jury verdicts: what
    language and themes are resonating with juries?
  • Analysis of active and unfriendly jurisdictions
  • Keeping up with tort reform initiatives: peering behind the
    curtain on where the plaintiffs’ bar focusing its lobbying efforts
    and identifying defense advocacy issues to focus on for 2017
5:00 p.m. – 6:00 p.m. Pre-Registration and Welcoming Cocktail Reception

Tuesday, December 6, 2016
What Top Companies and Firms Expect from their “Go-To” Regional and Local Counsel
3:45 P.M. – 5:30 P.M.
Donald Bunnin (Invited)
Senior Litigation Counsel
Allergan, Inc.
(Irvine, CA)
Richard W. Silbert
Vice President and Chief Litigation Counsel
Purdue Pharma L.P.
(Stamford, CT)
David L. Kleinman
Head US Litigation and Investigations
Sandoz Inc. (Princeton, NJ)
Michael X. Imbroscio
Covington and Burling LLP
(Washington, DC)
Back by popular demand: Designed to provide inside insights from both in-house and national trial counsel, this intimate networking
group will leave attendees armed with new contacts and improved knowledge of what top companies and firms expect from their “go-to”
team members.
  • Examining in-house and law firm counsels’ “pet peeves”
    with regards to their outside counsel – what behavior/
    activities/style should be avoided?
  • Comparing the various models for counsel roles- national,
    regional, local or by areas of expertise
  • Who is responsible for what? (e.g., evidence, discovery,
    appellate, Daubert and related scientific issues)
  • Demystifying the selection process: what criteria are
    companies using to select national law firm counsel to
    represent them
  • What is the process for becoming a manufacturer’s
    preferred provider?
  • How do the smaller firms get in the game?
  • Tips for regional and liaison counsel: how can you most
    benefit and be a resource to your trial team?
  • Jury selection
  • Ensuring local court practices and filings are appropriately
    adhered to
  • Providing additional support as appropriate
  • Dealing with the tremendous pressure to reduce costs and
    slash budgets in light of increased costs to life sciences
  • Increasing outside counsel’s performance while decreasing
    costs: metrics for effectiveness and efficiency

Copyright© 2016 American Conference Institute. All Rights Reserved